Features
CAR T-Cell Therapy Brings New Hope to Cancer Patients at Stanford Health Care
CAR T-cell therapy offers a new treatment option for patients with certain blood cancers who did not response to other treatments.
COVID-19 Updates: COVID-19 Resources » Vaccine Update » Updated Visitor Policy » What We're Doing to Keep You Safe »
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
Get the iPhone MyHealth app »
Get the Android MyHealth app »
The Stanford Blood and Marrow Transplant Program combines 25 years of treatment expertise, state-of-the-art research and comprehensive support services to provide the best possible outcomes. Offering treatment for malignant and non-malignant diseases, including lymphoma, myeloma, leukemia, myelodysplastic syndromes, and selected solid tumors, our program strives to integrate each patient into normal, everyday life.
Are you a patient or physician interested in CAR-T gene therapy? To make an appointment with one of our cancer specialists, call 650-498-6000.
The multispecialty approach of the Blood and Marrow Transplant team ensures quality patient care. In addition to our dedicated doctors, outstanding nursing care is provided by an experienced team of nurses which includes registered nurses, nurse coordinators, nurse practitioners, clinical nurse specialists, research nurses, and nursing assistants. The team also consists of physician assistants, pharmacists, dieticians, financial coordinators, social workers, physical therapists, laboratory technologists, chaplains, and an experienced administrative and clerical staff.
CAR T-cell therapy offers a new treatment option for patients with certain blood cancers who did not response to other treatments.
To commemorate the 30-year anniversary of blood and marrow transplantation at Stanford, the BMT program held a celebration for its more than 300 faculty, nurses and staff on Nov. 2, 2017.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Review the New Patient Packet for information about:
The initial evaluation process begins with a referral from your hematologist or oncologist to a Stanford Blood and Marrow Transplantation Program doctor. After this referral, the Stanford Blood and Marrow Transplant Program new patient coordinator will call you with an appointment date and time.
Bring completed forms found in the BMT New Patient Letter.
Please fax the Medical Record Release Form to your new patient coordinator. The medical release form is an authorization form for external facilities to release medical records to Stanford Health Care.
International Patients
Phone: +1 650-723-8561
Email: IMS@stanfordhealthcare.org
Phone: 1-866-742-4811
Fax: 650-320-9443
Monday – Friday, 8:30 a.m. – 5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referring Physicians.
Email or fax a cancer referral form with supporting documentation to ReferralCenter@stanfordhealthcare.org or 650-320-9443.
To make an appointment with one of our cancer specialists, call 650-498-6000.